Androgen receptor antagonists can result in changes in uptake of gallium Ga 68 gozetotide in prostate cancer. Effect on PET performance has not been established.
Source: NLP:kit for the preparation of gallium ga 68 gozetotide injection
Brand names: Gallium Ga-68 Psma-11
Radioactive Diagnostic Agent · Positron Emitting Activity
Route: Intravenous
Contraindications
4 CONTRAINDICATIONS None None ( 4 )
Pregnancy & Breastfeeding
8.1 Pregnancy Risk Summary Gallium Ga 68 Gozetotide Injection is not indicated for use in females. There are no available data with Gallium Ga 68 Gozetotide Injection use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. All radiopharmaceuticals, including Gallium Ga 68 Gozetotide Injection, have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose. Animal reproduction studies have not been conducted with gallium Ga 68 gozetotide.
2 interactions on record
Androgen receptor antagonists can result in changes in uptake of gallium Ga 68 gozetotide in prostate cancer. Effect on PET performance has not been established.
Source: NLP:kit for the preparation of gallium ga 68 gozetotide injection
ADT can result in changes in uptake of gallium Ga 68 gozetotide in prostate cancer. Effect on PET performance has not been established.
Source: NLP:kit for the preparation of gallium ga 68 gozetotide injection